Cargando…
Circulating tumor cells in head and neck cancer: A review
Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures for early detection and disease aggressiveness....
Autores principales: | McMullen, Kyle P., Chalmers, Jeffrey J., Lang, Jas C., Kumar, Pawan, Jatana, Kris R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698518/ https://www.ncbi.nlm.nih.gov/pubmed/29204555 http://dx.doi.org/10.1016/j.wjorl.2016.05.003 |
Ejemplares similares
-
Advancing theranostics with tumor-targeting peptides for precision otolaryngology
por: Wright, Chadwick L., et al.
Publicado: (2016) -
Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015) -
Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer
por: Schaefer, C, et al.
Publicado: (2005) -
Cervicopectoral flap in head and neck cancer surgery
por: Copcu, Eray, et al.
Publicado: (2003) -
Special issue “The advance of solid tumor research in China”: 68Ga‐PSMA‐11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma
por: Li, Yilin, et al.
Publicado: (2022)